Buch, Englisch, 251 Seiten, Format (B × H): 160 mm x 241 mm, Gewicht: 5751 g
ISBN: 978-0-85729-792-1
Verlag: Springer
This book aims to provide an up-to-date review of the literature in each of the major areas relating to the management of older lung cancer patients, and makes recommendations for best practice and future research. The authors come from a broad geographic spread including the UK, mainland Europe and North America to ensure a worldwide relevance.
Zielgruppe
Professional/practitioner
Autoren/Hrsg.
Fachgebiete
- Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Klinische und Innere Medizin Geriatrie, Gerontologie
- Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Klinische und Innere Medizin Pneumologie, Atmung, Asthma
- Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Klinische und Innere Medizin Onkologie, Krebsforschung
Weitere Infos & Material
1. Basic Science of Lung Cancer in Older Patients.- 2. Clinical Epidemiology and the Impact of Comorbidity on Treatment and Outcome.- 3. Physiological Assessment and Cardiopulmonary Exercise Testing.- 4. A Practical Mini-Guide to Geriatric Assessment.- 5. Impact of the Physiological Effects of Aging on the Pharmacokinetics and Pharmacodynamics of Systemic Lung Cancer Treatment.- 6. Drug Interactions and Polypharmacy.- 7. Selection of Appropriate Surgery for Early Lung Cancer.- 8. Surgery: Indications and Issues.- 9. Is There a Role for Postoperative Radiotherapy in Elderly Patients with Early Stage Non-Small Cell Lung Cancer?.- 10. Is There a Role for Neoadjuvant Chemotherapy in Older Patients?.- 11. Curative Radiotherapy in Patients Inoperable for Medical Reasons.- 12. Adjuvant Chemotherapy: Feasibility in the Elderly and Patient Selection.- 13. Locally Advanced Non-Small Cell Lung Cancer in the Elderly: What Combination of Therapy is Best?.- 14. First-Line Treatment and the New Paradigm of Histology-Based Treatment.- 15. Treatment of Frail Patients and Octogenarians with Advanced NSCLC.- 16. Are Second- and Third-Line Treatments in the Elderly Feasible?.- 17. Treatment of Limited Stage Disease in Older Patients: The Role of Thoracic Radiotherapy and Prophylactic Cranial Irradiation.- 18. Chemotherapy in the Elderly: Standard Chemotherapy or Specific Regimens?
